Cargando…
NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice
Background: The pathogenesis of sepsis-associated encephalopathy (SAE) is complicated, while the efficacy of current treatment technologies is poor. Therefore, the discovery of related targets and the development of new drugs are essential. Methods: A mouse model of SAE was constructed by intraperit...
Autores principales: | Chen, Lu, Qing, Wenxiang, Yi, Zexiong, Lin, Guoxin, Peng, Qianyi, Zhou, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313765/ https://www.ncbi.nlm.nih.gov/pubmed/34327209 http://dx.doi.org/10.3389/fnut.2021.701760 |
Ejemplares similares
-
KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway
por: Xu, Wenjing, et al.
Publicado: (2022) -
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
por: Coffey, Kelly, et al.
Publicado: (2012) -
Soy Protein Alleviates Malnutrition in Weaning Rats by Regulating Gut Microbiota Composition and Serum Metabolites
por: Wei, Zuchen, et al.
Publicado: (2021) -
C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice
por: Zhang, Yubing, et al.
Publicado: (2022) -
Dietary compounds in modulation of gut microbiota-derived metabolites
por: Feng, Wuwen, et al.
Publicado: (2022)